AU2002221520A1 - Vaccine composition containing transforming growth factor alpha - Google Patents

Vaccine composition containing transforming growth factor alpha

Info

Publication number
AU2002221520A1
AU2002221520A1 AU2002221520A AU2002221520A AU2002221520A1 AU 2002221520 A1 AU2002221520 A1 AU 2002221520A1 AU 2002221520 A AU2002221520 A AU 2002221520A AU 2002221520 A AU2002221520 A AU 2002221520A AU 2002221520 A1 AU2002221520 A1 AU 2002221520A1
Authority
AU
Australia
Prior art keywords
growth factor
composition containing
vaccine composition
transforming growth
factor alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002221520A
Other versions
AU2002221520B2 (en
Inventor
Anabel Alvarez Acosta
Gisela Maria Gonzalez Marinello
Gerardo Enrique Guillen Nieto
Tamara Menendez Medina
Aillette Mulet Sierra
Rolando Perez Rodriguez
Belinda Sanchez Ramirez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Immunologia Molecular
Original Assignee
Centro de Immunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CU20000286A external-priority patent/CU23077A1/en
Application filed by Centro de Immunologia Molecular filed Critical Centro de Immunologia Molecular
Publication of AU2002221520A1 publication Critical patent/AU2002221520A1/en
Priority to AU2007203242A priority Critical patent/AU2007203242B8/en
Application granted granted Critical
Publication of AU2002221520B2 publication Critical patent/AU2002221520B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002221520A 2000-12-06 2001-12-06 Vaccine composition containing transforming growth factor alpha Ceased AU2002221520B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2007203242A AU2007203242B8 (en) 2000-12-06 2007-07-12 Vaccine composition containing transforming growth factor alpha

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU20000286A CU23077A1 (en) 2000-12-06 2000-12-06 VACCINE COMPOSITION CONTAINING TRANSFORMING GROWTH FACTOR (TGF-ALFA). ITS USE IN MALIGNAL DISEASE THERAPY
CU286/2000 2000-12-06
PCT/CU2001/000011 WO2002045738A2 (en) 2000-12-06 2001-12-06 Vaccine composition containing transforming growth factor alpha

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2007203242A Division AU2007203242B8 (en) 2000-12-06 2007-07-12 Vaccine composition containing transforming growth factor alpha

Publications (2)

Publication Number Publication Date
AU2002221520A1 true AU2002221520A1 (en) 2002-08-22
AU2002221520B2 AU2002221520B2 (en) 2007-10-11

Family

ID=34109588

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002221520A Ceased AU2002221520B2 (en) 2000-12-06 2001-12-06 Vaccine composition containing transforming growth factor alpha
AU2152002A Pending AU2152002A (en) 2000-12-06 2001-12-06 Vaccine composition containing transforming growth factor alpha

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2152002A Pending AU2152002A (en) 2000-12-06 2001-12-06 Vaccine composition containing transforming growth factor alpha

Country Status (21)

Country Link
US (1) US20030054011A1 (en)
EP (1) EP1339425B1 (en)
JP (1) JP2004521091A (en)
KR (1) KR100834383B1 (en)
CN (2) CN101406692A (en)
AR (1) AR031785A1 (en)
AT (1) ATE439855T1 (en)
AU (2) AU2002221520B2 (en)
BR (1) BR0116017A (en)
CA (1) CA2430621A1 (en)
CU (1) CU23077A1 (en)
DE (1) DE60139633D1 (en)
EA (1) EA006240B1 (en)
ES (1) ES2332125T3 (en)
MX (1) MXPA03005031A (en)
MY (1) MY141122A (en)
NZ (1) NZ526283A (en)
PE (1) PE20020696A1 (en)
UY (1) UY27060A1 (en)
WO (1) WO2002045738A2 (en)
ZA (1) ZA200304416B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22979A1 (en) * 2000-12-08 2004-09-09 Centro Inmunologia Molecular IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF TUMORS OVER-EXPRESSING RECEPTORS WITH KINASE ACTIVITY IN TYPOSINE WASTE
CU23204A1 (en) * 2002-12-27 2007-05-18 Ct Ingenieria Genetica Biotech COMBINATIONS OF REGULATORY FACTORS OF GROWTH AND HORMONES FOR THE TREATMENT OF NEOPLASIAS
EP1493445A1 (en) * 2003-07-04 2005-01-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibition of stress-induced ligand-dependent EGFR activation
CU23297A1 (en) * 2004-11-16 2008-07-24 Ct De Inmunologa A Molecular IMMUNOTHERAPY / 00UTICAL FORMULATIONS FOR THE INDUCTION OF BLOCKING AUTHORTIC BODIES OF THE INTERLEUCINE-2 UNION TO ITS RECEIVER. ITS USE IN THE TREATMENT OF CÃ NCER
CU23652A1 (en) * 2007-06-29 2011-05-27 Centro Inmunologia Molecular HOMOGENOUS VACCINE COMPOSITION FOR THE TREATMENT OF CANCER AND ITS METHOD OF OBTAINING
KR101323845B1 (en) 2011-01-21 2013-10-31 광주과학기술원 Pharmaceutical Compositions for Treatment of Cancer Comprising Outer Membrane Vesicles as an Active Ingredient
CN113855792B (en) * 2021-12-01 2022-03-01 上海惠盾因泰生物科技有限公司 Recombinant hEGF-CRM197 tumor therapeutic vaccine formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651949B2 (en) * 1989-07-14 1994-08-11 American Cyanamid Company Cytokine and hormone carriers for conjugate vaccines
IL98528A0 (en) * 1990-06-21 1992-07-15 Merck & Co Inc Pharmaceutical compositions containing hybrid for killing bladder cancer cells
CU22302A1 (en) * 1990-09-07 1995-01-31 Cigb Codifying nucleotidic sequence for a protein of the external membrane of neisseria meningitidis and the use of that protein in preparing vaccines.
CA2261433A1 (en) * 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
GB2333706A (en) * 1998-02-02 1999-08-04 Merck & Co Inc Method for increasing muscle mass in animals

Similar Documents

Publication Publication Date Title
AU6421101A (en) Surgical clip
AU2001271749A1 (en) Bone preparation instruments
AU2001255846A1 (en) Dental implant system
AU2001229712A1 (en) Reduction of hair growth
AU2001244731A1 (en) Hair growth stimulant compositions
AU2002246666A1 (en) Anti-icing composition
AU2001258801A1 (en) Gelling composition
AU2002342653A1 (en) Modified growth hormone
AU2001270206A1 (en) Dental implant
AU2001280908A1 (en) Rotavirus vaccine formulations
AU2001267707A1 (en) Antiperspirant formulations
AU2001293728A1 (en) Cosmetic composition
AU2329300A (en) Dental implant system
AU2001290239A1 (en) Medicinal composition
AU1513801A (en) Antiperspirant compositions comprising microemulsions
AU2002210298A1 (en) Dental implant
AU2002221520A1 (en) Vaccine composition containing transforming growth factor alpha
AU2002210433A1 (en) Dental compositions
AU2152002A (en) Vaccine composition containing transforming growth factor alpha
AU2001267693A1 (en) Antiperspirant formulations
AU2001244729A1 (en) Hair growth stimulant compositions
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2001267541A1 (en) Vaccine composition
AU2001223721A1 (en) Dental compositions
AU2001245950A1 (en) Preparation of deoxynucleosides